Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease primary myelofibrosis
Symptom C0027022|myeloproliferative disease
Sentences 1
PubMedID- 20801055 We have studied tgfbeta1 levels in philadelphia-negative (ph-) myeloproliferative diseases, evaluating patients with primary myelofibrosis (pmf) that is characterized by increased numbers of circulating progenitor cells and bone marrow (bm) fibrosis, and patients with polycythemia vera (pv) or essential thrombocythemia (et) that do not present bm fibrosis.

Page: 1